Terrence Rindler
About Terrence Rindler
Terrence Rindler is the Director of New Technology Commercialization at Bristol Myers Squibb, with over 18 years of experience in the biotechnology and pharmaceutical industries.
Current Title and Role
Terrence Rindler currently holds the title of Director, New Technology Commercialization at Bristol Myers Squibb in Summit, New Jersey. In this role, he oversees the commercialization of new technologies within the pharmaceutical sector. His responsibilities likely include guiding projects from the development stage through to market introduction while ensuring that all regulatory and quality standards are met.
Work Experience at Bristol Myers Squibb
Terrence Rindler has been a part of Bristol Myers Squibb since 2020. He initially held the position of Associate Director, New Technology Commercialization for two years before being promoted to his current role as Director. His work in Summit, New Jersey has focused on the development and market launch of innovative pharmaceutical technologies, leveraging his extensive background in validation and automation processes.
Previous Roles and Experience
Before joining Bristol Myers Squibb, Terrence Rindler worked at Celgene from 2018 to 2020 as Associate Director, Technical Validation. Prior to that, he was with Juno Therapeutics from 2014 to 2018 as Associate Director, Validation. His earlier career included significant time at Dendreon, where he served in various roles from 2004 to 2014, culminating in the position of Sr. Manager, Validation. He began his career as an Engineering Laboratory Technician at NSF International in 2004.
Educational Background
Terrence Rindler studied Chemical Engineering at the University of Michigan, where he achieved a Bachelor of Science in Engineering (BSE). His educational background provided a strong foundation in engineering principles, which he has applied throughout his 18-year career in the biotechnology and pharmaceutical industries.
Industry Specializations and Expertise
With over 18 years of experience in the biotechnology and pharmaceutical industries, Terrence Rindler specializes in the commercialization of new technologies. His expertise also extends into the realms of validation and automation processes within the biotech sector. His career demonstrates a transition from technical validation roles to more strategic commercialization roles, underscoring his comprehensive understanding of both the technical and market aspects of pharmaceutical technology development.